RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
Go back to RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.36 +0.22 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.14 | 52 Week High | $108.63 | |||
| Open | $136.81 | 52 Week Low | $71.39 | |||
| Day High | $138.43 | P/E | 76.44 | |||
| Day Low | $135.91 | EPS | $1.81 | |||
| Volume | 3,407,717 | |||||
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $16.54 | |||
| Open | $0.59 | 52 Week Low | $8.10 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.58 | EPS | $0.00 | |||
| Volume | 8,260 | |||||
